Stocktoria
BeyondSpring Inc. BYSI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-03-09
BeyondSpring Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1.4M | $1.4M | $180,000 | $0 | $0 | $0 | $0 |
| R&D expense | $4.4M | $2.6M | $7.3M | $25.6M | $36.9M | $41.8M | $31.3M | $51.6M | $88.9M | $10.4M |
| SG&A expense | $4.6M | $6.1M | $7.8M | $13.0M | $30.7M | $22.6M | $9.0M | $5.9M | $9.1M | $1.9M |
| Operating income | -$8.9M | -$8.8M | -$15.1M | -$37.2M | -$66.2M | -$64.2M | -$40.3M | -$57.5M | -$98.0M | -$12.4M |
| Interest expense | — | — | — | $17,000 | $87,000 | $85,000 | $206,000 | — | — | — |
| Income tax | $90,000 | $96,000 | -$92,000 | $163,000 | $3.6M | $0 | $0 | — | — | — |
| Net income | -$1.0M | -$11.1M | -$21.0M | -$33.3M | -$64.2M | -$61.0M | -$38.1M | -$54.9M | -$91.8M | -$12.0M |
| Operating cash flow | -$19.8M | -$16.4M | -$16.5M | -$27.5M | -$47.2M | -$43.7M | -$48.2M | -$40.0M | -$28.8M | -$13.7M |
| Free cash flow | -$19.8M | -$16.7M | -$16.6M | -$27.5M | -$50.1M | -$43.8M | -$48.2M | -$40.2M | -$28.9M | -$13.8M |
| Cash & equivalents | $7.8M | $2.9M | $5.4M | $34.4M | $41.6M | $109.5M | $35.9M | $3.9M | $27.5M | $11.7M |
| Total assets | $25.9M | $34.3M | $24.8M | $46.2M | $81.6M | $117.0M | $44.6M | $7.1M | $32.8M | $14.9M |
| Total liabilities | $49.9M | $48.6M | $48.3M | $49.2M | $55.3M | $25.2M | $13.4M | $16.4M | $4.8M | $2.6M |
| Shareholders' equity | -$32.2M | -$32.9M | -$35.3M | -$14.1M | $26.7M | $88.3M | $31.1M | -$9.4M | $28.0M | $12.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -100.0% | +0.0% | +650.6% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.